Introduction
Thyroid carcinoma is an uncommon malignancy, accounting for approximately 1% of total cancer cases. In the year 2002, the annual age standardized (world) incidence was estimated to be 3.3 per 100,000 among women and 1.3 per 100,000 among men (Ferlay et al., 2004) .
The thyroid gland is highly sensitive to radiation-induced oncogenesis. This is verified by numerous reports from survivors after the bombings of Hiroshima and Nagasaki, several atomic-bomb tests and the accident at Chernobyl. Also, earlier medical use of radiation for benign diseases in childhood was associated with thyroid malignancy (Nagataki and Nystrom, 2002) .
Other than ionizing radiation, the aetiology of thyroid neoplasms remain relatively obscure but epidemiological studies have implicated benign thyroid nodules and goitre, hormonal and reproductive variables, lifestyle, dietary intakes and genetic factors (Ron, 1996) . Differences in iodine intake may be one factor explaining the geographic variation, high iodine intake being associated with a slightly increased risk of developing papillary thyroid cancer although low iodine intake leads to increased risk of follicular carcinoma.
Over the past decades, upward incidences of the trend of papillary thyroid cancer have been reported in several countries, such as Sweden (Pettersson et al., 1991) , Norway (Akslen et al., 1990 (Akslen et al., , 1993 , England & Wales (Dos Santos Silva and Swerdlow, 1993) , France (Colonna et al., 2002) and Connecticut, USA (Zheng et al., 1996) . In addition to the known aetiological factors, increased diagnostic activity has been proposed for explaining the observed increase (Verkooijen et al., 2003; Leenhardt et al., 2004) . We used the existing data collected by the Swiss Cancer registries network (ASRT/VSKR) (http://www.asrt.ch) to analyse trends in thyroid cancer during the last available 20 years, and to make withincountry geographical comparisons for current incidence rates.
Material and methods
In Switzerland, cancer data are currently collected by a network of nine cancer registries, covering 56% of the Swiss population, organized by the Swiss Association of Cancer Registries (ASRT/VSKR). Each registry collects all new cancer cases occurring in the population of the related canton: Geneva since 1970, Neuchâtel and Vaud since 1974, St Gall-Appenzell and Zurich since 1980, Basel since 1981, Graubünden-Glarus and Valais since 1989 and Ticino since 1996 (Table 1) . All data are merged into a central database, with common rules for data collection and coding. Quality control procedures have been arranged on the basis of guidelines developed by European Network of Cancer Registries (http:// www.encr.com.fr/). In our registries, neoplastic pathologies are coded according to the International Classification of Diseases for Oncology (ICD-O), version 1, 2 or 3, depending on registration time, and all translated into the version 2 (Percy et al., 1990) when combined in the central database.
All incident invasive carcinomas (behaviour code: 3) of thyroid cancer (Topography: C73.9) registered during the period 1980-1999 were included, regardless of stage at diagnosis. They have been classified into two groups according to ICD-O(2) morphology codes: 'papillary' group (M8340, papillary carcinoma, follicular variant (21% of all thyroid cancers); M8260, papillary adenocarcinoma, NOS (17%); M8050, papillary carcinoma NOS (14%); M8290, papillary carcinoma with oxyphilic cells (6%)) represents 58% of thyroid cancer (Table 2) , and 'not papillary' group in which there are six subtypes only (M8330, follicular adenocarcinoma, NOS (22%); M8020, carcinoma, undifferentiated type, NOS (4%; M8021, carcinoma, anaplastic type, NOS (4%); M8510, medullary carcinoma, NOS (3%); M8331, follicular adenocarcinoma well differenciated (2%) and M8511, medullary carcinoma with amyloid stroma (2%)) represent 37% of thyroid cancer. Each of the other non-papillary subtypes met (8000, 8004, 8010, 8012, 8030, 8031, 8032, 8033, 8041, 8070, 8071, 8072, 8140, 8230, 8240, 8310, 8332, 8350, 8560, 8800, 8810, 8830, 8890, 8980, 9120, 9130, and 9150) represents less than 1% of thyroid cancer, and only 6% all together.
Incidence rates
Annual crude rates and age-standardized rates per 100,000 using the European population as a standard were calculated for all morphologies combined and for papillary and non-papillary cases separately.
Geographical comparisons were performed estimating the incidence rate ratio (IRR) and 95% confidence intervals (95% CI) (Boyle and Parkin, 1991) using Graubünden-Glarus, the registry with the lowest incidence rates in both sexes, as a reference. In addition, incidence data during the period 1996-1998 from eight registries (all but Zurich) were used for inter-cantonal comparisons. 1980-1984 1985-1989 1990-1994 1995-1999 1980-1999 
Linear trend analysis
Data available were combined to perform an analysis of time trends. To investigate changes in thyroid cancer risk over the examined period, regression models were fitted to the annual age standardized (European) incidence rates by sex and morphologic group to obtain their estimated annual percent change (EAPC) over time.
Changes in rates among different age groups were also estimated and compared. The models were fitted using STATA (Stata Statistical Software, 2003) .
Joinpoint analysis
The joinpoint regression model describes continuous changes in rates and uses the grid search method to fit the regression function with unknown joinpoints (points in time where significant changes in the trend occurred) assuming constant variance and uncorrelated errors. The analysis, performed with the statistical software Joinpoint (Kim et al., 2000) , is useful to characterize the trends in cancer rates succinctly and by connecting linear line segments on a log scale it allows to estimate recent changes in trend.
Briefly, to determine the number of joinpoints (in this example, up to two), the procedure first tests the hypothesis of no change against the alternative of two joinpoints. If the null hypothesis is rejected, then the similar procedure is applied to test the null hypothesis of one joinpoint against the alternative of two joinpoints. Otherwise, the null hypothesis of no change is tested against the alternative of one joinpoint. Such a sequence of permutation tests allows the number of significant joinpoints to be estimated. The resulting best linear regression model is applied to the data, estimating annual percent changes and 95% CIs for each time segment consequently identified (for more details see Kim et al., 2000) .
Age period cohort models
Age period cohort (APC) models provide a summary of the time trend data, allowing a formal statistical examination of whether temporal trends are due to secular changes in risk (period effects) or changes in risk from generation to generation (birth cohort effects) in different populations. The pooled data from all Swiss crude rates were organized in twelve 5-year age groups (20-24 to 75-79 years old), four 5-year periods of diagnosis (1980-1984 to 1995-1999) , and fifteen 10-year overlapping birth cohorts , identified by midpoint year (e.g., the birth cohort 1945 comprised subjects born between 1940 and 1949).
The effects of age, cohort of birth and period of diagnosis were estimated by fitting a log-linear Poisson model to the age-specific incidence rates Schifflers, 1987a, 1987b) . A sequence of models was fitted starting with the one-factor age model (model A), proceeding to the two-factor age-drift, age-period and age-cohort models, and finally to the full three-factor APC model, testing the statistical significance of the effect of the term added at each step by way of forwarding likelihood ratio test, choosing the simplest model (H0 hypothesis) as the best one when the test was not significant. The deviance/degrees of freedom ratio was used to assess the goodness-of-fit for each model and a resulting value of 1.50 or less was taken as an indication of satisfactory goodness-of-fit (Francis et al., 1993) . The 1920 birth cohort was chosen as the cohort reference category, as it was the first one that was observed in every diagnostic 5-year period. The models were fitted using STATA.
Results

Descriptive analysis and geographical comparison
The total number of cancer cases, total person-years and age standardized (European) incidence rates for each Swiss cancer registry by sex and morphology are reported in Table 1 . As expected, incidence rates are much higher among women than among men (5.60 vs. 2.52 in all Swiss registries combined).
The IRR for all morphologies ranges between 1.41 and 2.29 among men and between 1.24 and 1.65 among women when Graubünden-Glarus is used as a reference and with majority of them reaching statistical significance in both sexes.
Geographical comparison continues comparing age standardized (European) incidence rates observed by eight registries during the most recent period 1996-1998 ( Fig. 1) . Incidence rates for all morphologies combined ranges from 1.62 (Graubünden-Glarus) to 2.99 (Valais) among males and from 2.13 (Graubünden-Glarus) to 8.09 (Basel) among females. There are some differences in the rank of registries by sex (Valais and Neuchatel rank first among men and among the last among women). Even differences by morphology are detectable, as the papillary form was largely the most common in quite all registries, except Valais, Basel and Graubünden-Glarus among men.
In particular, the papillary subtype varies from 33.3% (Valais) to 87.5% (Geneva) among males and from 50% (Graubünden-Glarus) to 84.2% (Ticino) among females.
Pooled time trend analysis
Over the period 1980-1999, regression analyses for both sexes combined (Fig. 2(a) ) detected an increase for papillary cases and a decrease for non-papillary cases, with stable trends when all morphologies are combined. Looking at trends by sex ( Fig. 2(b) ), similar behaviour was observed for each morphological subtype, even if rates decreased more steeply among men. Estimated annual percent changes and related 95% CIs showed that none of the trends examined changed significantly, except for the decrease of all morphologies combined and the non-papillary cases among males over 70 years of age. Trends for papillary cases (a non-significant increase) and non-papillary cases (a non-significant decrease) were consistent through all ages among males. Among females both thyroid cancer subtypes increased among the youngest women and decreased among oldest, while the 1980 1986 1992 1998 1980 1986 1992 1998 1980 1986 1992 1998 1980 1986 1992 1998 1980 1986 1992 1998 1980 1986 1992 1998 Year Observed and fitted European age-standardized incidence rates (EASR, per 100,000, age 0-85 + ) of thyroid cancer in pooled Swiss cancer registries (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) . middle-aged group showed a behaviour similar to men (i.e., a non-significant increase for papillary cases and a non-significant decrease for non-papillary cases) ( Table 3) .
The analyses performed using Joinpoint confirmed the estimated annual percent changes values obtained via Poisson regression and did not reveal any statistically significant change in recent trends, excepting for all sexes and all morphologies combined, for which two changepoints (1992 and 1997) in rates trend were observed, creating a peak of incidence in 1997 ( Fig. 3) .
Age, period and cohort models
Age-cohort models fitted the observed data better than other models (the deviance/degrees of freedom ratio was 1.50 or less) and the introduction of the cohort variable in the analysis always improved significantly the models (P-value of change in deviance < 0.05), even when the age-drift model fitted the data satisfactorily (Table 4 ). The cohort effect was particularly evident when thyroid cancer cases of both sexes and all morphologies combined were examined (P-value of change in deviance < 0.0001 after introduction of the cohort variable in the model). When the models were performed dividing data in subsets (by morphology and sex), the evidence of effects slowly faded away. On the contrary, no significant nonlinear period effect was observed. However, the cohortspecific risks related to the reference birth cohort (1920) began to increase from subjects (sex combined) born around 1940 when all morphologies were considered, while the increase started with 1925 born cases for papillary subtype, counterbalanced by a deficit of not papillary subtype ( Fig. 4(a) ). Quite the same behaviour has been shown when the analysis was conducted by sex, but with wider CIs (Fig. 4(b and c) ).
Discussion
Our retrospective observation of incidence rates for all types of thyroid cancer in Switzerland showed an increase during the last 20 years, with some evidence of significant changes in trends. This consideration was based on both the analysis of linear time trends, and an in-depth statistical analysis looking for any specific birth cohort and period effect, by sex and histological subtype.
Among the morphologies that thyroid cancer can assume, papillary cancers showed steeply increasing trends. Whether these trends really reflected naturally increasing incidence rates or they were artificial, represents an authentic concern. In fact, recent studies demonstrated that they are likely due to increased diagnostic activity or changes in histological criteria. The diagnostic criteria for the histological classification of thyroid tumours have been subject to changes over the past decades. These changes have favoured the diagnosis of the papillary subtype at the expense of the follicular one and might explain part of the increased papillary cancer incidence (Verkooijen et al., 2003) .
On the other hand, when Pacini et al. (1997 Pacini et al. ( , 1999 compared the characteristics of patients less than 21 years old observed in Belarus with those observed in Italy and France, they found that, even if papillary carcinomas accounted for most of the thyroid tumours in both series, the proportion of this histotype was clearly greater in Belarus than in the Western European centres, whereas the reverse was true for follicular carcinomas.
In order to evaluate the reliability of thyroid cancer diagnoses, Abelin et al. (1994) scrutinized histological slides of 120 cases (out of 160 = 75%) reported among children up to 15 years old by the Belarus tumour registry 3 -3.0 to 7.6 2.7 -3.3 to 8.8 0.9 -9.9 to 11.7 45-69 0.1 -2.9 to 3.1 2.0 -1.9 to 6.0 -2.9 -7.7 to 2.0 70 + -2.5 -4.6 to 0.4 -0.2 -3.7 to 3.9 -3.7 -6.3 to 1.1 (1986) (1987) (1988) (1989) (1990) (1991) (1992) and carcinoma was confirmed in 94% of revised tumours and all cases except one were of the papillary type. Franc et al. (2003) organized a histological review of 327 randomly selected thyroid cancer cases listed in adult registries from Ukraine and Belarus (1980-1999) , finding an agreement of 94%, 40% and 33% for 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 Year of diagnosis Observed and fitted crude incidence rates for thyroid cancer in Switzerland, sexes and morphologies combined, obtained by way of Joinpoint analysis. Two joinpoints (JP) were detected at 1992 and 1997, providing the following segments and related EAPCs: segment 1 (1980-1992) = -0.86 ( -2.42 to 0.73) segment 2 (1992-1997) = 5.56 ( -1.98 to 13.68) segment 3 (1997-1999) = -19.62 ( -40.27 to 8.18) papillary, follicular and medullary thyroid carcinomas, respectively. This possible 'misclassification' actually reflects the changes in histological definitions and pathologists' knowledge on thyroid cancer over the entire period. Such a trend, already described, could explain only part of the opposite trends 'in mirror' for the papillary/non-papillary histological subtypes.
Other studies revealed light increases in thyroid cancer incidence rates in recent years. Colonna et al. (2002) found a yearly increase of 6.2% among men and 8.1% among women in France (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) , while Verger et al. (2003) suggested that the Chernobyl fallout could not explain the entire increase in thyroid cancer in France. Murbeth et al. (2004) found a statistically significant 2.0% increase during the period 1976-1999 and an additional 2.6% after 1990 in the Czech Republic. Thyroid cancer was estimated to be among those significantly increased in a comprehensive study in central Italy (Crocetti et al., 2002) and data from the Italian Association of Cancer Registries confirmed significant increases among both men (EAPC, + 3.4%) and women (EAPC, + 4.6%) (Casella and Fusco, 2004) . In the UK a significant increase in the incidence of thyroid cancer after the Chernobyl accident was detected and the increase was greater in the area receiving the heaviest fallout, supporting a causal relationship of the temporal and spatial changes in incidence consistent with the Chernobyl accident (Cotterill et al., 2001) . A study on this topic in canton of Vaud, Switzerland, discovered a moderate increase in both genders (Levi et al., 2002) . In Sweden, Lundgren et al. (2003) found a significant increase of papillary thyroid cancer over time, while a trend was not observed for follicular thyroid cancer. It should be emphasized that the majority of these studies discuss the possible influence of screening effects, incidentally discovered cases linked to the use of modern diagnostic tools and do not fail to detect changes in histological classification, with some increase in papillary thyroid cancer and decrease (or no change) in other ones.
The observation of the risk heterogeneity within Switzerland is reflected by the discrepancies in incidence rates observed by the tumour registries. Several issues deserve to be discussed and some results from the trends analysis by sex and subtypes raised some other questions and hypothesis. As the histological confirmation rates are steadily higher than 95% and Death Certificates Only (DCO) rates are null or < 0.5% everywhere, accuracy and validity cannot be in doubt. However, the historical evolution of our data set over time with successive entries of registries could partially explain the peculiar result obtained by joinpoint analysis when data for all morphologies and sexes combined were analysed. A pair of simulations has been performed, mainly aiming to understand the role of Zurich missing data after 1996, as it was the largest registry in terms of person-years and its incidence rates were amongst the highest in Switzerland. When the Zurich registry was completely excluded from the analysis, the slope of the trend did not change abruptly, while, keeping the incidence in Zurich constant after 1996, only the first joinpoint (around 1990) was still detectable and EAPC for the period 1990-1999 showed a significant increase of the rates (EAPC 2.6, 95% CI 0.2-5.05). These results force any final conclusion about the incidence in the latter period to be deferred, while an increase after 1990 appears sufficiently likely.
The considerations described above are evidently linked to a further critical point: how could data be combined?
We identified two main options: either (1) to preserve the continuity by taking the data provided by the six oldest registries only (i.e., Basel, Geneva, Neuchatel, St Gall-Appenzell, Vaud and Zurich) from 1981 to 1996, thus causing a lack of geographical representation, or (2) including all registries in the analysis, regardless of period covered, in order to build up a data set as representative as possible of the current Swiss incidence. As linear trend analysis using these two options gave consistent results, the second solution was chosen.
In an APC analysis, the effects of possible aetiological factors are studied indirectly, using calendar period and birth cohorts as proxy variables. Regular trends in increasing risk over time is well described by the cohort effect: for successive cohorts after the one born around 1920, overall risk regularly increased ( Fig. 4(a, b and c) ) and the most recent changes (1970) (1971) (1972) (1973) (1974) (1975) could be attributed to random variation. Improvement in diagnostic techniques could be an acceptable, although partial, explanation for such a regular trend, as for successive cohorts presenting (almost) similar age specific risk of cancer, more efficient awareness and investigations leaded to discover more cancers than in the past.
We did not observe any non-linear period effect, even if it could have been expected when an exposure at a specific time (e.g., the Chernobyl accident) could be suspected to affect all cohorts. One may argue that we have followed the population for about 10-15 years after 1986, which might not be long enough, and although the shortest latency period is supposed to be around 4 years among the youngest exposed (Sadetzki et al., 2003; Kikuchi et al., 2004) the major effect could take longer time to be fully observed. Our data could support this possibility as the EAPC for all morphologies (mainly due to papillary subtype) increased among both sexes for the 0-44 class of age (Table 4) . A greater susceptibility of the youngest people to ionizing radiation could explain this increase in the most recent birth cohorts only. However, as this estimate was not significant, we cannot reject the null hypothesis of no actual change. A longer period is needed to observe a continuous increase of risk, if any, among the youngest cohorts and to gain statistical power for more reliable conclusions
Conclusions
Even if the study presents some limitations and possible biases, it is clear that incidence rates of thyroid cancer are changing in Switzerland, as in most European countries. In addition, our data show a greater increase for most recent cohorts, especially for people less than 26 years old in 1986, and a further increase can be expected over the next few years (Pacini et al., 1997; Catelinois et al., 2004) . However, the period of monitoring (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) was relatively short in terms of carcinogenic processes, although thyroid cancer is known to present one of the shortest latency periods after a person is exposed to ionizing radiation. Therefore, the statistical power of our current data is not yet sufficient to determine whether or not this increase is related to the general trend or could be related to any specific exposure. Consequently, continuous study of this topic should be encouraged.
